Barriers to Participation in Actual HIV Vaccine Trials

被引：5

作者：

Dhalla, Shayesta ^{[1
]}

Poole, Gary ^{[2
]}

机构：

[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada

来源：

CURRENT HIV RESEARCH | 2013年 / 11卷 / 03期

关键词：

Actual trials; barriers; HIV; vaccine; EFFICACY TRIAL; SOCIAL-ISSUES; HIGH-RISK; VOLUNTEERS; THAILAND; DISCRIMINATION; RECRUITMENT; ENROLLMENT; INFECTION; BEHAVIOR;

D O I：

10.2174/1570162X11311030009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Cognitive barriers to participation in actual HIV vaccine trials have not been previously comprehensively reviewed. In this review article, barriers in actual early phase, phase 2B, and phase 3 HIV vaccine trials are quantified and categorized, and compared between the Organization for Economic Co-operation and Development (OECD) countries and the non-OECD countries. Participation rates were standardized to allow for comparisons. In both the OECD and the non-OECD countries, barriers included subjective norms and discrimination, vaccine safety concerns, and logistical concerns. More actual HIV vaccine trials can incorporate questions about and quantify barriers to participation, and this may aid future recruitment strategies.

引用

页码：238 / 245

页数：8

共 26 条

[1] Trial-related discrimination in HIV vaccine clinical trials [J].

Allen, M ;

Israel, H ;

Rybczyk, K ;

Pugliese, MA ;

Loughran, K ;

Wagner, L ;

Erb, S .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (08) :667-674

[2] Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers [J].

Belshe, RB ;

Stevens, C ;

Gorse, GJ ;

Buchbinder, S ;

Weinhold, K ;

Sheppard, H ;

Stablein, D ;

Self, S ;

McNamara, J ;

Frey, S ;

Flores, J ;

Excler, JL ;

Klein, M ;

El Habib, R ;

Duliege, AM ;

Harro, C ;

Corey, L ;

Keefer, M ;

Mulligan, M ;

Wright, P ;

Celum, C ;

Judson, F ;

Mayer, K ;

McKirnan, D ;

Marmor, M ;

Woody, G .

JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) :1343-1352

[3] Determinants of enrollment in a preventive HIV vaccine trial [J].

Buchbinder, SP ;

Metch, B ;

Holte, SE ;

Scheer, S ;

Coletti, A ;

Vittinghoff, E .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :604-612

[4] Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note [J].

Chesney, MA ;

Chambers, DB ;

Kahn, JO .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (04) :266-271

[5] Lessons from a multisite International trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120 [J].

Cleghorn, Farley ;

Pape, Jean W. ;

Schechter, Mauro ;

Bartholomew, Courtenay ;

Sanchez, Jorge ;

Jack, Noreen ;

Metch, Barbara J. ;

Hansen, Marianne ;

Allen, Mary ;

Cao, Huyen ;

Montefiori, David C. ;

Tomaras, Georgia D. ;

Gurunathan, Sanjay ;

Eastman, Donna J. ;

do Lago, Regina F. ;

Jean, Sonic ;

Lama, Javier R. ;

Lawrence, Dale N. ;

Wright, Peter F. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) :222-230

[6] Reasons for Not Participating in a Phase 1 Preventive HIV Vaccine Study in a Resource-Rich Country [J].

Constanza Lucero, Maria ;

Diaz-Brito, Vicens ;

Torres Murillo, Berta ;

Corral Carretero, Saray ;

Sala, Marta ;

Casadesus, Cristina ;

Sanchez Conde, Matilde ;

Luis Jimenez, Jose ;

Pich, Judit ;

Albert Arnaiz, Joan ;

Leon, Agathe ;

Perez, Inaki ;

Munoz-Fernandez, Ma Angeles ;

Gatell, Jose M. ;

Plana, Montserrat ;

Esteban, Mariano ;

Bernaldo de Quiros, Juan Carlos ;

Garcia, Felipe .

AIDS PATIENT CARE AND STDS, 2012, 26 (07) :379-382

[7] Barriers of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studies [J].

Dhalla, Shayesta ;

Poole, Gary .

VACCINE, 2011, 29 (35) :5850-5859

[8]

Fishbein M., 1975, BELIEF ATTITUDE INTE, DOI DOI 10.2307/2065853

[9] Negative social impacts among volunteers in an HIV vaccine efficacy trial [J].

Fuchs, Jonathan ;

Durham, Marcus ;

McLellan-Lemal, Eleanor ;

Vittinghoff, Eric ;

Colfax, Grant ;

Gurwith, Marc ;

Buchbinder, Susan .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (03) :362-368

[10] Participation in two phase II prophylactic HIV vaccine trials in the UK [J].

Gray, Kimberly ;

Legg, K. ;

Sharp, A. ;

Mackie, N. ;

Olarinde, F. ;

De Souza, C. ;

Weber, J. ;

Peters, B. .

VACCINE, 2008, 26 (23) :2919-2924

← 1 2 3 →